Tech Company Financing Transactions
ProNAi Therapeutics Funding Round
ProNAi Therapeutics secured a $6.7 million funding round on 10/25/2006. Investors included Amherst Fund, Grand Angels and Michigan Economic Development Corporation.
Transaction Overview
Company Name
Announced On
10/25/2006
Transaction Type
Venture Equity
Amount
$6,650,000
Round
Undisclosed
Proceeds Purpose
The CEO stated, "Team ProNAi is delighted at the success of our bridge financing round, which will help us bring our lead drug candidate, PNT-100, toward submission to the FDA as an Investigational New Drug sometime in mid-2007. Our drug development team is making remarkable progress in developing this very promising therapeutic, and we look forward to additional compelling efficacy and safety outcomes."
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
885 West Georgia St. 2150
Vancouver BC, V6C 3E8
Canada
Vancouver BC, V6C 3E8
Canada
Phone
Website
Email Address
Overview
ProNAi Therapeutics, Inc. (NASDAQ: DNAI) is a biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi, to advance a next generation of therapies for patients with cancer and other complex genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nick Glover
Chief Financial Officer
Sukhi Jagpal
VP - Human Resources
Diane Gardiner
VP - Manufacturing
Simon Eastman
VP - Operations
Wendy Chapman
VP - R & D
Emma McCann
VP - Regulatory Affairs
Chandra Lovejoy
Browse more venture capital transactions:
Prev: 10/25/2006: Coveo venture capital transaction
Next: 10/25/2006: MonoSphere venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs